CALTON & ASSOCIATES, INC. – Neurocrine Biosciences, Inc. Transaction History
CALTON & ASSOCIATES, INC. portfolio value:
$235,000
portfolio value
CALTON & ASSOCIATES, INC. quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -2.33% | -53 shares | 14K | $106.21 | 2.22K |
| Q2 2022 | share | Decrease | -4.97% | -119 shares | -3K | $97.48 | 2.27K |
| Q1 2022 | share | Increase | 0.00% | 2.39K shares | 224K | $93.75 | 2.39K |
| Q4 2021 | share | Decrease | -100.00% | -2.26K shares | -217K | $84.63 | 0 |
| Q3 2021 | share | Decrease | -0.79% | -18 shares | -5K | $95.91 | 2.26K |
| Q2 2021 | share | Decrease | -2.98% | -70 shares | -7K | $97.32 | 2.28K |
| Q1 2021 | share | Decrease | -0.04% | -1 shares | 4K | $97.25 | 2.35K |
| Q4 2020 | share | Increase | 0.00% | 2.35K shares | 225K | $95.85 | 2.35K |
| Q3 2020 | share | Decrease | -100.00% | -1.87K shares | -229K | $96.16 | 0 |
| Q2 2020 | share | Increase | 0.00% | 1.87K shares | 229K | $122 | 1.87K |
| Q1 2020 | share | Decrease | -100.00% | -1.99K shares | -215K | $86.55 | 0 |
| Q4 2019 | share | Increase | 0.00% | 1.99K shares | 215K | $107.49 | 1.99K |